Patients with dilated cardiomyopathy possess insulin resistance independently of cardiac dysfunction or serum tumor necrosis factor-α

Yumiko Sakai, Toru Maruyama, Hitoshi Katsuta, Kazuhiko Kogawa, Tomoyuki Akashi, Ken Ichi Izumi, Hiroyuki Tominaga, Suminori Kono, Seiho Nagafuchi, Mine Harada

Research output: Contribution to journalArticle

Abstract

It has recently been reported that insulin resistance is prevalent in patients with dilated cardiomyopathy (DCM); however, it remains unclear whether insulin resistance is directly induced by DCM or if it is caused by congestive heart failure associated with DCM. We evaluated homeostasis model assessment insulin resistance (HOMA-R) in 14 patients with DCM in comparison with 9 patients with valvular heart diseases (VHD). We also measured the level of serum tumor necrosis factor (TNF)-α as a possible causative factor for inducing insulin resistance. Even after the adjustment for age, body mass index, and cardiac function, HOMA-R was significantly higher in patients with DCM than in those with VHD (P = 0.012) (mean ± SEM: 3.51 ± 0.59, and 0.80 ± 0.64, respectively). The serum TNF-α level tended to be higher in patients with DCM than in those with VHD; however, the difference was not significant. In conclusion, patients with DCM possess insulin resistance independently of the severity of cardiac dysfunction or serum TNF-α, suggesting that insulin resistance in patients with DCM may be closely associated with the pathogenic condition of DCM itself.

Original languageEnglish
Pages (from-to)877-887
Number of pages11
JournalInternational heart journal
Volume47
Issue number6
DOIs
Publication statusPublished - Feb 1 2007

Fingerprint

Dilated Cardiomyopathy
Insulin Resistance
Tumor Necrosis Factor-alpha
Serum
Heart Valve Diseases
Homeostasis
Body Mass Index
Heart Failure

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Patients with dilated cardiomyopathy possess insulin resistance independently of cardiac dysfunction or serum tumor necrosis factor-α. / Sakai, Yumiko; Maruyama, Toru; Katsuta, Hitoshi; Kogawa, Kazuhiko; Akashi, Tomoyuki; Izumi, Ken Ichi; Tominaga, Hiroyuki; Kono, Suminori; Nagafuchi, Seiho; Harada, Mine.

In: International heart journal, Vol. 47, No. 6, 01.02.2007, p. 877-887.

Research output: Contribution to journalArticle

Sakai, Yumiko ; Maruyama, Toru ; Katsuta, Hitoshi ; Kogawa, Kazuhiko ; Akashi, Tomoyuki ; Izumi, Ken Ichi ; Tominaga, Hiroyuki ; Kono, Suminori ; Nagafuchi, Seiho ; Harada, Mine. / Patients with dilated cardiomyopathy possess insulin resistance independently of cardiac dysfunction or serum tumor necrosis factor-α. In: International heart journal. 2007 ; Vol. 47, No. 6. pp. 877-887.
@article{e1c2d2755c604197b64ca1488a78381e,
title = "Patients with dilated cardiomyopathy possess insulin resistance independently of cardiac dysfunction or serum tumor necrosis factor-α",
abstract = "It has recently been reported that insulin resistance is prevalent in patients with dilated cardiomyopathy (DCM); however, it remains unclear whether insulin resistance is directly induced by DCM or if it is caused by congestive heart failure associated with DCM. We evaluated homeostasis model assessment insulin resistance (HOMA-R) in 14 patients with DCM in comparison with 9 patients with valvular heart diseases (VHD). We also measured the level of serum tumor necrosis factor (TNF)-α as a possible causative factor for inducing insulin resistance. Even after the adjustment for age, body mass index, and cardiac function, HOMA-R was significantly higher in patients with DCM than in those with VHD (P = 0.012) (mean ± SEM: 3.51 ± 0.59, and 0.80 ± 0.64, respectively). The serum TNF-α level tended to be higher in patients with DCM than in those with VHD; however, the difference was not significant. In conclusion, patients with DCM possess insulin resistance independently of the severity of cardiac dysfunction or serum TNF-α, suggesting that insulin resistance in patients with DCM may be closely associated with the pathogenic condition of DCM itself.",
author = "Yumiko Sakai and Toru Maruyama and Hitoshi Katsuta and Kazuhiko Kogawa and Tomoyuki Akashi and Izumi, {Ken Ichi} and Hiroyuki Tominaga and Suminori Kono and Seiho Nagafuchi and Mine Harada",
year = "2007",
month = "2",
day = "1",
doi = "10.1536/ihj.47.877",
language = "English",
volume = "47",
pages = "877--887",
journal = "International Heart Journal",
issn = "1349-2365",
publisher = "International Heart Journal Association",
number = "6",

}

TY - JOUR

T1 - Patients with dilated cardiomyopathy possess insulin resistance independently of cardiac dysfunction or serum tumor necrosis factor-α

AU - Sakai, Yumiko

AU - Maruyama, Toru

AU - Katsuta, Hitoshi

AU - Kogawa, Kazuhiko

AU - Akashi, Tomoyuki

AU - Izumi, Ken Ichi

AU - Tominaga, Hiroyuki

AU - Kono, Suminori

AU - Nagafuchi, Seiho

AU - Harada, Mine

PY - 2007/2/1

Y1 - 2007/2/1

N2 - It has recently been reported that insulin resistance is prevalent in patients with dilated cardiomyopathy (DCM); however, it remains unclear whether insulin resistance is directly induced by DCM or if it is caused by congestive heart failure associated with DCM. We evaluated homeostasis model assessment insulin resistance (HOMA-R) in 14 patients with DCM in comparison with 9 patients with valvular heart diseases (VHD). We also measured the level of serum tumor necrosis factor (TNF)-α as a possible causative factor for inducing insulin resistance. Even after the adjustment for age, body mass index, and cardiac function, HOMA-R was significantly higher in patients with DCM than in those with VHD (P = 0.012) (mean ± SEM: 3.51 ± 0.59, and 0.80 ± 0.64, respectively). The serum TNF-α level tended to be higher in patients with DCM than in those with VHD; however, the difference was not significant. In conclusion, patients with DCM possess insulin resistance independently of the severity of cardiac dysfunction or serum TNF-α, suggesting that insulin resistance in patients with DCM may be closely associated with the pathogenic condition of DCM itself.

AB - It has recently been reported that insulin resistance is prevalent in patients with dilated cardiomyopathy (DCM); however, it remains unclear whether insulin resistance is directly induced by DCM or if it is caused by congestive heart failure associated with DCM. We evaluated homeostasis model assessment insulin resistance (HOMA-R) in 14 patients with DCM in comparison with 9 patients with valvular heart diseases (VHD). We also measured the level of serum tumor necrosis factor (TNF)-α as a possible causative factor for inducing insulin resistance. Even after the adjustment for age, body mass index, and cardiac function, HOMA-R was significantly higher in patients with DCM than in those with VHD (P = 0.012) (mean ± SEM: 3.51 ± 0.59, and 0.80 ± 0.64, respectively). The serum TNF-α level tended to be higher in patients with DCM than in those with VHD; however, the difference was not significant. In conclusion, patients with DCM possess insulin resistance independently of the severity of cardiac dysfunction or serum TNF-α, suggesting that insulin resistance in patients with DCM may be closely associated with the pathogenic condition of DCM itself.

UR - http://www.scopus.com/inward/record.url?scp=33846928007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846928007&partnerID=8YFLogxK

U2 - 10.1536/ihj.47.877

DO - 10.1536/ihj.47.877

M3 - Article

VL - 47

SP - 877

EP - 887

JO - International Heart Journal

JF - International Heart Journal

SN - 1349-2365

IS - 6

ER -